Review: Long-acting β2-adrenoceptor agonists are effective in poorly reversible chronic obstructive pulmonary disease

Shafazand, Shirin
January 2007
ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p18
Academic Journal
The article discusses the effectiveness of using long-acting β2-adrenoceptor agonists (LABA) on patients with chronic obstructive pulmonary disease (COPD) and poor reversibility to short-acting bronchodilators. Studies reveal that LABAs reduce exacerbations and improve the functioning of lungs. COPD in patients is also the major reason for morbidity and mortality.


Related Articles

  • Cardiovascular Safety of Î’ 2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease. Salpeter, Shelley R. // Drugs & Aging;2004, Vol. 21 Issue 6, p405 

    Background: β2-Adrenoceptor agonists have been used as bronchodilators in the management of asthma and chronic obstructive pulmonary disease (COPD); however, there is evidence suggesting that β2-adrenoceptor agonist use may increase morbidity and mortality. Methods: A systematic review of...

  • Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Deshpande, Deepak A.; Wang, Wayne C. H.; McIlmoyle, Elizabeth L.; Robinett, Kathryn S.; Schillinger, Rachel M.; An, Steven S.; Sham, James S. K.; Liggett, Stephen B. // Nature Medicine;Nov2010, Vol. 16 Issue 11, p1299 

    Bitter taste receptors (TAS2Rs) on the tongue probably evolved to evoke signals for avoiding ingestion of plant toxins. We found expression of TAS2Rs on human airway smooth muscle (ASM) and considered these to be avoidance receptors for inhalants that, when activated, lead to ASM contraction and...

  • Is there a rational for combining long-acting antimuscarinics and β2-agonists? Calzetta, Luigino; Capuano, Annalisa; Rinaldi, Barbara; Matera, Maria G. // Hot Topics in Respiratory Medicine;2014, Vol. 9 Issue 26, p7 

    Asthma and COPD are airway diseases both affected by as of yet not well-elucidated genetic and environmental interactions. Chronic inflammation underlies both diseases. Both conditions involve the small airways, causing a slightly larger decrease in airway function and both cause airway...

  • Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database. Jara, Michele; Lanes, Stephan F.; Wentworth III, Charles; May, Corey; Kesten, Steven; Wentworth, Charles 3rd // Drug Safety;2007, Vol. 30 Issue 12, p1151 

    Background: Use of a long-acting inhaled bronchodilator, either an anticholinergic or a beta-adrenergic receptor agonist (beta-agonist), is recommended for maintenance treatment of chronic obstructive pulmonary disease (COPD). In COPD, the organ system most frequently requiring...

  • ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of β2-Adrenoreceptor Desensitized Tracheas. Israël-Assayag, Evelyne; Beaulieu, Marie-Josée; Cormier, Yvon // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Inhaled β2-adrenoreceptor agonists are widely used in asthma and chronic obstructive pulmonary disease (COPD) for bronchoconstriction relief. β2-adrenoreceptor agonists relax airway smooth muscle cells via cyclic adenosine monophosphate (cAMP) mediated pathways. However, prolonged...

  • What Defines Abnormal Lung Function in Older Adults with Chronic Obstructive Pulmonary Disease? Bhatt, Nitin Y.; Wood, Karen L. // Drugs & Aging;2008, Vol. 25 Issue 9, p717 

    Chronic obstructive pulmonary disease (COPD) is a very common lung disease most often related to a history of smoking. It becomes more prevalent with increasing age but remains under-diagnosed and under-treated in the elderly population. The Global Initiative for Obstructive Lung Disease...

  • Acute exacerbations. Currie, Graeme P.; Wedzicha, Jadwiga A. // BMJ: British Medical Journal (International Edition);7/8/2006, Vol. 333 Issue 7558, p87 

    The article discusses exacerbations of chronic obstructive pulmonary disease (COPD) and related symptoms. These exacerbations can be caused by viruses, bacteria, or environmental pollutants. Oxygen therapy, bronchodilators, corticosteroids, antibiotics, aminophylline, respiratory stimulants,...

  • Inhaled Salmeterol: A Review of its Efficacy in Chronic Obstructive Pulmonary Disease. Jarvis, B.; Markham, A. // Drugs & Aging;2001, Vol. 18 Issue 6, p441 

    Inhaled salmeterol is a long-acting, selective β-adrenoceptor agonist bronchodilator. The drug has been compared with placebo, ipratropium bromide and oral theophylline in patients with chronic obstructive pulmonary disease (COPD) in randomised, clinical trials. Inhaled salmeterol 50µg...

  • New COPD guidelines urge use of drug still under study. Hitchens, Kathy // Drug Topics;8/18/2003, Vol. 147 Issue 16, pHSE7 

    Reports on the Global Initiative for Chronic Obstructive Lung Disease's issuance of an updated guidelines chronic obstructive pulmonary disease (COPD). Recommendation of bronchodilator tiotropium for maintenance COPD therapy; Reclassification of the staging of COPD.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics